Alzheimer’s Disease Diagnostic Market Size, Trends and Insights by Type (Early-onset Alzheimer’s, Late-onset Alzheimer’s, Familial Alzheimer’s disease), Diagnostic test (Genetic testing, Neurological exam, Mini-mental state exam (MMSE), Brain imaging), End Users (Clinics, Hospitals, Diagnostic Centers ), Competitive Market Growth, Size, Share and Forecast to 2030
New York, May 24, 2023 (GLOBE NEWSWIRE) — Alzheimer’s Disease Diagnostic Market Overview
According to a Comprehensive Research Report by Market Research Future (MRFR), “Alzheimer’s Disease Diagnostic Market Information by Type, Diagnostic Test, End Users, and Region – Forecast till 2030”, Market is expected to reach USD 7,100 Million by 2030 at 8.90% CAGR during the forecast period 2022-2030.
Market Scope
Alzheimer’s Disease Diagnostic market refers to the market for medical devices and tools used to diagnose Alzheimer’s disease, which is a type of dementia that affects memory, thinking, and behavior. The market includes various diagnostic tests such as brain imaging, blood tests, and genetic testing.
The market for Alzheimer’s Disease Diagnostics is expected to grow significantly in the coming years, driven by factors such as the increasing prevalence of Alzheimer’s disease globally, rising geriatric population, and growing awareness about the importance of early diagnosis of the disease.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/2149
Report Scope:
| Report Attribute | Details |
| Market Size in 2030 | USD 7,100 Million |
| CAGR | 8.90% |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Type, Diagnostic Test and End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Market Drivers | Growth of chronic diseases worldwide like dementia |
| Technological advancement, macro economical and governing factors |
Alzheimer’s Disease Diagnostic Market Competitive Landscape:
The affluent companies in the Alzheimer’s Disease Diagnostic industry include
- Eli Lilly and Company
- TauRx (Republic of Singapore)
- Alector LLC
- Accera, Inc
- Treventis Corporation
- Neuro-Bio Ltd
- Cognition Therapeutics Inc
- Hoffmann-La Roche
- Novartis AG
- Merck & Co
- Pfizer Inc
- Allergan PLC
- Daiichi Sankyo Co
June 2022
Diadem SpA announced the development of AlzoSure Predict, which is a first-of-its-kind, non-invasive blood test to predict the early onset of Alzheimer’s disease (AD). The company has partnered with Dementias Platform UK to advance its efforts.
June 2022
SYNAPS Dx (SDx) announced its focus on research and development in the area of neurological disorder diagnostics, including Alzheimer’s disease. The company is also working towards commercialization and uses Alzheimer’s & Brain Awareness Month in June to raise awareness of brain disorders and Alzheimer’s disease as significant health concern for the public.
Alzheimer’s Disease Diagnostic Market Trends:
Market Drivers:
One major driver in the Alzheimer’s Disease Diagnostic market is the increasing prevalence of Alzheimer’s disease globally. As the population ages, the incidence and prevalence of Alzheimer’s disease are expected to rise, creating a greater demand for accurate and reliable diagnostic tools. Alzheimer’s disease is a neurodegenerative disorder that causes a progressive decline in cognitive function, including memory loss, language difficulties, and impaired judgment. It is the most common cause of dementia in older adults, and the number of people living with Alzheimer’s disease is projected to increase significantly in the coming years. The growing prevalence of Alzheimer’s disease has led to a growing demand for diagnostic tools that can accurately detect the disease in its early stages. Early diagnosis is critical for effective management of the disease and can help improve patient outcomes. As a result, there is an increasing need for reliable and accurate diagnostic tools that can help identify Alzheimer’s disease early on.
Market Restraints:
A major restraint for the Alzheimer’s Disease Diagnostic market is the high cost of diagnostic tests and procedures. Many diagnostic tools, such as brain imaging tests, can be costly and may not be covered by insurance, making them less accessible to certain patient populations. In addition, the high cost of developing and obtaining regulatory approval for new diagnostic tests can be a significant barrier to entry for companies looking to enter the market. These factors may limit the growth of the Alzheimer’s Disease Diagnostic market, particularly in regions with limited healthcare infrastructure or lower levels of healthcare spending
Browse In-depth Market Research Report (90 Pages) on Alzheimer’s Disease Diagnostic: https://www.marketresearchfuture.com/reports/alzheimers-disease-diagnostic-market-2149
COVID 19 Analysis
The COVID-19 pandemic has had a significant impact on the Alzheimer’s disease diagnostic market. Due to the pandemic, many healthcare facilities were overwhelmed with COVID-19 patients, which led to a reduction in the number of Alzheimer’s disease diagnoses and delays in treatment. This has resulted in a decline in the demand for Alzheimer’s disease diagnostic tests and services. Furthermore, the pandemic has also disrupted the supply chain for Alzheimer’s disease diagnostic products, causing delays in manufacturing and distribution. This has led to a shortage of diagnostic tests and other products, which has further impacted the market.
Alzheimer’s Disease Diagnostic Market Segmentation
By Type
The types in the market include Early-onset Alzheimer’s, Late-onset Alzheimer’s, and Familial Alzheimer’s disease.
By Diagnostics test
By diagnostics test the segment includes Genetic testing, Neurological exam, Mini-mental state exam (MMSE), Brain imaging
By end-user
By end-user, the segment includes Clinics, Hospitals, Diagnostic Centers
Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=2149
Regional Insights
The North American region is one of the largest markets for Alzheimer’s Disease Diagnostic due to the high prevalence of the disease in the region. The US, in particular, is the largest market in this region, owing to a large geriatric population and a high incidence rate of Alzheimer’s disease. Additionally, the well-established healthcare infrastructure and the presence of major players in the region are driving the market growth.
The European market for Alzheimer’s Disease diagnostics is also growing due to the rising geriatric population and increasing prevalence of Alzheimer’s disease. The market is driven by the presence of major players in the region, advanced healthcare infrastructure, and favorable government initiatives to promote early diagnosis of the disease. The UK, Germany, France, and Spain are the major markets in the region.
The Asia Pacific region is expected to witness significant growth in the Alzheimer’s Disease Diagnostic market due to the increasing prevalence of the disease, a growing geriatric population, and improving healthcare infrastructure. The market is also driven by increasing government initiatives to promote early diagnosis and treatment of Alzheimer’s disease. Japan, China, India, and South Korea are some of the major markets in the region.
Discover more research Reports on Healthcare Industry by Market Research Future:
DNA Sequencing Market Research Report Information By Product (Consumable, Instrument, and Service), By Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, and Forensics), By Technology (Semiconductor Sequencing, Sequencing by Ligation, and Pyrosequencing), By End-User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.
Genetic Testing Market Size amd Trends Analysis By Type (Prescribed Genetic Testing and Direct-to-Consumer Genetic Testing), Method (Molecular Genetic Tests/ DNA Tests, Chromosomal Genetic Tests and Biochemical Genetic Tests), By Application (Reproductive Health (Newborn Screening, Prenatal Screening and Carrier Screening), Cancer Screening (Hereditary Cancer, Breast Cancer, Ovarian Cancer and Colon Cancer), Ancestry, Predictive and Pre-Symptomatic Testing and others) – Forecast till 2030
Cancer Diagnostics Market Size, Trends and Industry Outlook by Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer and others), End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn | Twitter
CONTACT: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com
- ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages The Walt Disney Company Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DIS - June 1, 2023
- ROSEN, A LEADING NAITONAL FIRM, Encourages Telephone and Data Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TDS, TDSPrU, TDSPrV - June 1, 2023
- Global Pet Food Market Expected to Cross US$ 220.4 Billion at CAGR of 6.4% during forecast period of 2023 to 2033 | Data analysis by Future Market Insights, Inc. - June 1, 2023
